Cargando…
Bioinformatics for precision oncology
Molecular profiling of tumor biopsies plays an increasingly important role not only in cancer research, but also in the clinical management of cancer patients. Multi-omics approaches hold the promise of improving diagnostics, prognostics and personalized treatment. To deliver on this promise of prec...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585151/ https://www.ncbi.nlm.nih.gov/pubmed/29272324 http://dx.doi.org/10.1093/bib/bbx143 |
_version_ | 1783428651845419008 |
---|---|
author | Singer, Jochen Irmisch, Anja Ruscheweyh, Hans-Joachim Singer, Franziska Toussaint, Nora C Levesque, Mitchell P Stekhoven, Daniel J Beerenwinkel, Niko |
author_facet | Singer, Jochen Irmisch, Anja Ruscheweyh, Hans-Joachim Singer, Franziska Toussaint, Nora C Levesque, Mitchell P Stekhoven, Daniel J Beerenwinkel, Niko |
author_sort | Singer, Jochen |
collection | PubMed |
description | Molecular profiling of tumor biopsies plays an increasingly important role not only in cancer research, but also in the clinical management of cancer patients. Multi-omics approaches hold the promise of improving diagnostics, prognostics and personalized treatment. To deliver on this promise of precision oncology, appropriate bioinformatics methods for managing, integrating and analyzing large and complex data are necessary. Here, we discuss the specific requirements of bioinformatics methods and software that arise in the setting of clinical oncology, owing to a stricter regulatory environment and the need for rapid, highly reproducible and robust procedures. We describe the workflow of a molecular tumor board and the specific bioinformatics support that it requires, from the primary analysis of raw molecular profiling data to the automatic generation of a clinical report and its delivery to decision-making clinical oncologists. Such workflows have to various degrees been implemented in many clinical trials, as well as in molecular tumor boards at specialized cancer centers and university hospitals worldwide. We review these and more recent efforts to include other high-dimensional multi-omics patient profiles into the tumor board, as well as the state of clinical decision support software to translate molecular findings into treatment recommendations. |
format | Online Article Text |
id | pubmed-6585151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-65851512019-06-25 Bioinformatics for precision oncology Singer, Jochen Irmisch, Anja Ruscheweyh, Hans-Joachim Singer, Franziska Toussaint, Nora C Levesque, Mitchell P Stekhoven, Daniel J Beerenwinkel, Niko Brief Bioinform Paper Molecular profiling of tumor biopsies plays an increasingly important role not only in cancer research, but also in the clinical management of cancer patients. Multi-omics approaches hold the promise of improving diagnostics, prognostics and personalized treatment. To deliver on this promise of precision oncology, appropriate bioinformatics methods for managing, integrating and analyzing large and complex data are necessary. Here, we discuss the specific requirements of bioinformatics methods and software that arise in the setting of clinical oncology, owing to a stricter regulatory environment and the need for rapid, highly reproducible and robust procedures. We describe the workflow of a molecular tumor board and the specific bioinformatics support that it requires, from the primary analysis of raw molecular profiling data to the automatic generation of a clinical report and its delivery to decision-making clinical oncologists. Such workflows have to various degrees been implemented in many clinical trials, as well as in molecular tumor boards at specialized cancer centers and university hospitals worldwide. We review these and more recent efforts to include other high-dimensional multi-omics patient profiles into the tumor board, as well as the state of clinical decision support software to translate molecular findings into treatment recommendations. Oxford University Press 2017-12-18 /pmc/articles/PMC6585151/ /pubmed/29272324 http://dx.doi.org/10.1093/bib/bbx143 Text en © The Author(s) 2017. Published by Oxford University Press. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Paper Singer, Jochen Irmisch, Anja Ruscheweyh, Hans-Joachim Singer, Franziska Toussaint, Nora C Levesque, Mitchell P Stekhoven, Daniel J Beerenwinkel, Niko Bioinformatics for precision oncology |
title | Bioinformatics for precision oncology |
title_full | Bioinformatics for precision oncology |
title_fullStr | Bioinformatics for precision oncology |
title_full_unstemmed | Bioinformatics for precision oncology |
title_short | Bioinformatics for precision oncology |
title_sort | bioinformatics for precision oncology |
topic | Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585151/ https://www.ncbi.nlm.nih.gov/pubmed/29272324 http://dx.doi.org/10.1093/bib/bbx143 |
work_keys_str_mv | AT singerjochen bioinformaticsforprecisiononcology AT irmischanja bioinformaticsforprecisiononcology AT ruscheweyhhansjoachim bioinformaticsforprecisiononcology AT singerfranziska bioinformaticsforprecisiononcology AT toussaintnorac bioinformaticsforprecisiononcology AT levesquemitchellp bioinformaticsforprecisiononcology AT stekhovendanielj bioinformaticsforprecisiononcology AT beerenwinkelniko bioinformaticsforprecisiononcology |